Clinical Trial

Factors Affecting Response to Extracorporeal Shock Wave Therapy in Plantar Fasciitis: A Cross-sectional Clinical Study

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated June 5, 2025 (before its estimated July 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Heel pain is a problem that affects daily life activities and quality of life. Extracorporeal shock wave therapy (ESWT) is a treatment used for heel pain. However, some people do not benefit from ESWT treatment. The aim of this study is to determine the factors that affect the response to ESWT in the treatment of heel pain.
Trial Details
NCT Number NCT07006389
Lead Sponsor Sisli Hamidiye Etfal Training and Research Hospital
Conditions Plantar Fasciitis, Plantar Heel Pain
Enrollment 128 participants
Start Date 2025-01-01
Primary Completion 2025-07-01 (estimated)
Study Completion 2025-07-01 (estimated)
Updated on ClinicalTrials.gov 2025-06-05